Romania’s Ambassador to Hungary, Gabriel Şopandă, is a well-known face among Budapest’s diplomatic corps. As his term in office nears its conclusion, he sat down with the BBJ to discuss his time here ...

Organon is terminating development of its endometriosis drug after the Phase II trial failed to show any benefit. The ELENA proof-of-concept study (NCT05560646) was evaluating Organon’s therapy, ...

A high-level overview of Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. (RGEDF) stock. View (RGEDF) real-time stock price, chart, news, analysis, analyst reviews and more.

Check out our RICHTER stock chart to see a history of performance, current stock value, and a timeline of financial events & indicators for a full analysis today.

Despite the slower Q1 growth, Gedeon Richter maintained its full-year 2025 guidance, projecting 10% CER growth in pharmaceutical revenues and clean EBIT. The company anticipates growth to accelerate ...

"We're proud to partner with Gedeon Richter, an organization whose global footprint and manufacturing excellence perfectly complement Granata Bio's strengths in the U.S. market.

The " Gedeon Richter House of Hope " was implemented by the Hungary-based Close to Africa Foundation in cooperation with its local partner, the Sini Sanuman Foundation.

The "Gedeon Richter House of Hope" was implemented by the Hungary-based Close to Africa Foundation in cooperation with its local partner, the Sini Sanuman Foundation.

BUDAPEST, Hungary, May 6, 2025 /PRNewswire/ -- A center providing healthcare and educational support as well as shelter for vulnerable women has been built in Bamako, the capital of Mali, with ...

Gedeon Richter markets the first globally available GnRH antagonist combination therapy, for the treatment of uterine fibroids and symptomatic endometriosis. The medicine combines multiple active ...